Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
For patients already managing type 2 diabetes and seeking metabolic optimization, the Foundayo Pill with Ongoing Care represents another option in the oral GLP-1 landscape
It helps coordinate appetite signals, supports healthy insulin response, and slows digestion so meals feel more satisfying
In one clinical trial, 1,961 participants experienced an average weight loss of 14.9% after taking 2.4mg of semaglutide for 68 weeks: Other studies demonstrate varying amounts lost, usually over six months to 68 weeks
While a dedicated cardiovascular outcomes trial has not yet been completed (the gold standard for proving cardiovascular protection), the available metabolic data strongly suggests meaningful cardioprotection
However, some situations warrant professional intervention
Over time, advances in science revealed underlying biological mechanisms that needed to be addressed through a multitude of methods, including in many cases, pharmaceutical intervention
US$ 29.45
US$ 28.09
US$ 24.60
US$ 21.58
US$ 20.71
US$ 27.16
US$ 21.65
US$ 21.21
US$ 23.36
US$ 28.86
